Finally, genome-wide association studies (GWAS) have consistently identified polymorphisms in the LRRK2 loci that associate with PD risk in sporadic populations (Satake et al., 2009; Simon-Sanchez et al., 2009; Sharma et al., 2012; Nalls et al., 2014). This evidence concerns the gene LRRK2 and Parkinson disease.